Halozyme Therapeutics, Inc. (HALO)
65.13
+0.84
(+1.31%)
USD |
NASDAQ |
Mar 17, 16:00
65.13
0.00 (0.00%)
After-Hours: 16:37
Halozyme Therapeutics Price : 65.13 for March 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 238.15 |
| Eli Lilly & Co. | 930.58 |
| Skye Bioscience, Inc. | 0.6723 |
| AIM ImmunoTech, Inc. | 0.7005 |
| Stryker Corp. | 349.14 |
Price Related Metrics
| PE Ratio | 26.14 |
| PS Ratio | 5.722 |
| Price to Book Value | 157.47 |
| Price to Free Cash Flow | 12.40 |
| Earnings Yield | 3.83% |
| Market Cap | 7.686B |
| Operating PE Ratio | 9.790 |
| Normalized PE Ratio | 14.19 |